Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triheptanoin for Glucose Transporter Type 1 Deficiency
NCT03181399Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2018
- Primary completion
- Sep 2023
- Modality
- SLNs, Nanostructured Lipid Carriers, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triheptanoin in Glucose Transporter Type 1 Deficiency Syndrome (Glut1DS), sponsored by UT Southwestern Medical Center. Started Apr 2018; status: completed.
02
Drugs
triheptanoin
03
Conditions
Glucose Transporter Type 1 Deficiency Syndrome (Glut1DS)
Beyond the preview
Go deeper on NCT03181399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03181399.